Skip to content

Pegaspargase

Oncaspar (pegaspargase) is an enzyme pharmaceutical. Pegaspargase was first approved as Oncaspar on 1994-02-01. It is used to treat b-cell chronic lymphocytic leukemia, blast crisis, non-hodgkin lymphoma, and precursor cell lymphoblastic leukemia-lymphoma in the USA. It has been approved in Europe to treat precursor cell lymphoblastic leukemia-lymphoma.
Trade Name Oncaspar
Common Name Pegaspargase
Indication b-cell chronic lymphocytic leukemia, blast crisis, non-hodgkin lymphoma, precursor cell lymphoblastic leukemia-lymphoma
Drug Class Enzymes; PEGylated compounds
Pegaspargase
Get full access now